Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Vascular endothelial growth factor C (VEGFC) ELISA Kit-Sandwich

Name: Canine Vascular endothelial growth factor C (VEGFC) ELISA Kit-Sandwich
SKU: EK10F919
Rating: 5 (1 reviews)

Cat. No.EK10F919

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Basket

Product Overview

BioVenic Canine VEGFC ELISA Kit-Sandwich is designed for the quantitative determination of Canine VEGFC in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine VEGFC.

Target Species Canine

Species Reactivity Canine

Detection Range 62.5-4000 pg/mL

Sensitivity 12.5 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

vascular endothelial growth factor C is encoded by the VEGFC gene in dogs. It is a member of the angiogenic growth factors.

Target/Biomarker Canine VEGFC

Target Synonym vascular endothelial growth factor C

Gene ID 482932

UniProt ID A0A8C0MVI4

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Alonso-Diez, Á. et al. Anti-angiogenic treatments interact with steroid secretion in inflammatory breast cancer triple negative cell lines.Cancers. 2021, 13: 3668.